MOLECULAR TEMPLATES INC's ticker is MTEM and the CUSIP is 608550109. A total of 104 filers reported holding MOLECULAR TEMPLATES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,902 | +23.2% | 25,431 | 0.0% | 0.00% | – |
| Q1 2023 | $9,661 | +15.8% | 25,431 | 0.0% | 0.00% | – |
| Q4 2022 | $8,342 | -56.1% | 25,431 | 0.0% | 0.00% | – |
| Q3 2022 | $19,000 | +58.3% | 25,431 | +90.1% | 0.00% | – |
| Q2 2022 | $12,000 | -98.2% | 13,380 | -73.3% | 0.00% | -100.0% |
| Q1 2020 | $666,000 | -36.6% | 50,138 | -33.3% | 0.00% | -33.3% |
| Q4 2019 | $1,051,000 | – | 75,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,137,991 | $8,381,000 | 6.85% |
| ACUTA CAPITAL PARTNERS, LLC | 322,500 | $1,264,000 | 0.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,021,317 | $4,004,000 | 0.46% |
| BVF INC/IL | 3,129,599 | $12,268,000 | 0.44% |
| Bellevue Group AG | 10,878,003 | $42,642,000 | 0.44% |
| FRAZIER MANAGEMENT LLC | 1,374,047 | $5,386,000 | 0.42% |
| Endurant Capital Management LP | 268,375 | $1,052,000 | 0.25% |
| Abingworth LLP | 200,000 | $780,000 | 0.19% |
| Parkman Healthcare Partners LLC | 147,728 | $579,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 145,329 | $570,000 | 0.07% |